Increased magnesium intake prevents hyperlipidemia and insulin resistance and reduces lipid peroxidation in fructose-fed rats

Pathophysiology

Volumn 14, Issue 1, 2007, Pages 11-15

  Olatunji, L A ^a   Soladoye, A O ^a  

^a UNIVERSITY OF ILORIN   (Nigeria)

Author keywords

Dietary magnesium; Fructose diet; Hyperlipidemia; Insulin; Lipid peroxidation

Indexed keywords

ASCORBIC ACID; FRUCTOSE; INSULIN; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MAGNESIUM; THIOBARBITURIC ACID REACTIVE SUBSTANCE; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; GLUCOSE BLOOD LEVEL; HOMEOSTASIS; HYPERGLYCEMIA; HYPERLIPIDEMIA; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPID BLOOD LEVEL; LIPID PEROXIDATION; MAGNESIUM BLOOD LEVEL; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 34247331012     PISSN: 09284680     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pathophys.2006.09.004     Document Type: Article

References (32)

1. Guthrie J.F., and Morton J.F. Food sources of added sweeteners in the diets of Americans. J. Am. Diet. Assoc. 100 (2000) 43-48
2. Hallfrisch J. Metabolic effects of dietary fructose. FASEB J. 4 (1990) 2625-2660
3. Gibney M., Sigman-Grant M., Stanton Jr. J.L., and Keast D.R. Consumption of sugar. Am. J. Clin. Nutr. 62 (1995) 1785-1935
4. Dai S., Todd M.E., Lee S., and McNeill J.H. Fructose loading induces cardiovascular metabolic changes in non-diabetic and diabetic rats. Can. J. Physiol. Pharmacol. 72 (1994) 771-781
5. Faure P., Rossini E., Lafond J.L., Richard M.J., Favier A., and Halimi S. Vitamin E improves the free radical defense system potential and insulin sensitivity of rat fed high fructose diets. J. Nutr. 127 (1997) 103-107
6. Reiser S., Powell A.S., Scholfield D.J., Panda P., Ellwood K.C., and Canary J.J. Blood lipids, lipoproteins, apoproteins and uric acid in men fed diets containing fructose or high amylase cornstarch. Am. J. Clin. Nutr. 49 (1989) 832-839
7. Olatunji L.A., Okwusidi J.I., and Soladoye A.O. Anti-diabetic effect of Anacardium occidentale stem-bark in fructose-diabetic rats. Pharm. Biol. 43 (2005) 589-593
8. Gingliano D., Ceriello A., and Paolisso G. Oxidative stress and diabetic vascular complications. Diabetes care 19 (1996) 257-267
9. Ozdemirler G., Mehmetcik G., Oztezcan S., Toker G., Sivas A., and Uysal M. Peroxidation potential and anti-oxidant activity of serum in patients with diabetes mellitus and myocardial infarction. Horm. Metab. Res. 27 (1995) 194-196
10. Gums J.G. Magnesium in cardiovascular and other disorders. Am. J. Health-Syst. Pharm. 61 (2004) 1569-1576
11. Rayssignier Y., Durlach J., Gueux E., Rock E., and Mazur A. Magnesium and ageing: experimental data importance of oxidative damage. Magnesium Res. 6 (1993) 369-378
12. de Lourdes L.M., Crua T., Pousada J.C., Rodrigues L.E., Barbosa K., and Canguru V. The effect of magnesium supplementation in increasing doses on the control of type 2 diabetes. Diabetes Care 21 (1998) 682-686
13. Paolisso G., Sgambato S., Pezza G., Passariello N., Varricchio M., and D'Onofrio F. Improved insulin response and action by chronic magnesium administration in aged NIDDM subjects. Diabetes Care 12 (1989) 265-269
14. Keenoy B.M., Moorkens G., Vertommen J., Noe M., Neve J., and de Leeuw I. Magnesium status and parameters of the oxidant-antioxidant balance in patients with chronic fatigue: effect of supplementation with magnesium. J. Am. Coll. Nutr. 19 (2000) 374-382
15. Haenni A., Ohrvall M., and Lithell H. Atherogenic lipid fractions are related to ionized magnesium status. Am. J. Clin. Nutr. 67 (1998) 202-207
16. Eibl N.L., Kopp H.P., Howak H.R., Schnack C.J., Hopmeier P.G., and Schernthaner G. Hypomagnesemia in type 2 diabetes: effect of a 3-month replacement therapy. Diabetes Care 18 (1995) 188-192
17. Matthew S.D., Hosker J., Rudenski A., Naylor B., Treacher D., and Tumer R. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28 (1995) 412-419
18. Friedwald W.T., Levy R.I., and Fredrickson D.S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma without use of preparative ultra centrifuge. Clin. Chem. 18 (1972) 499-502
19. Richard M.J., Portal B., Meo J., Coudray C., Hadjian A., and Favier A. Malondialdehyde kit evaluated for determination of plasma and lipoproteins functions that react with thiobarbituric acid. Clin. Chem. 38 (1992) 704-709
20. Zannoni V., Lynch M., Goldstein S., and Sato P.A. Rapid micromethod for the determination of ascorbic acid in plasma and tissues. Biochem. Med. 11 (1974) 42-48
21. Crapo P.A., and Kolterman O.G. The metabolic effects of 2-wk fructose feeding in normal subjects. Am. J. Clin. Nutr. 39 (1984) 525-534
22. Thorburn A.W., Crapo P.A., Beltz W.F., Wallace P., Witztum J.L., and Henry R.R. Lipid metabolism in non-insulin-dependent diabetes: effects of long-term treatment with fructose-supplemented mixed meals. Am. J. Clin. Nutr. 50 (1989) 1015-1022
23. Quchi Y., Tabata R., Stergiopoulos K., Sato F., Hattori A., and Orimo H. Effect of dietary magnesium on development of atherosclerosis in cholesterol-fed rabbits. Arteriosclerosis 10 (1990) 732-737
24. Kisters K., Spieker C., Tepel M., and Zidek W. New data about the effects of oral physiological magnesium supplementation on several cardiovascular risk factors (lipids and blood pressure). Magnesium Res. 6 (1993) 355-360
25. Rayssiguer Y., Noe L., and Etienne J. Effect of magnesium deficiency on post-heparin lipase activity and tissue lipoprotein lipase in the rats. Lipids 26 (1991) 182-186
26. Hara T., Cameron-Smith D., Cooney G., Kusunoki V.M., Tsutsumi K., and Storlien L.H. The action of a novel lipoprotein lipase activator, NO-1886, in hypertriglyceridemic fructose-fed rat. Metabolism 47 (1998) 149-153
27. Ruderman N.B., Williamson J.R., and Brownlee M. Glucose and diabetic vascular disease. FASEB J. 6 (1992) 2905-2914
28. Heinecke J.W. Oxidants and anti-oxidants in the pathogenesis of atherosclerosis: implications for the oxidized low-density lipoprotein hypothesis. Atherosclerosis 14 (1998) 1-15
29. Frei B., England L., and Ames B.N. Ascorbate is an outstanding anti-oxidant in human blood plasma. Proc. Natl. Acad. Sci. U.S.A. 86 (1989) 6377-6381
30. Garcia L.A., Dejong S.C., Martin S.M., Smith R.S., Buettner G.R., and Kerber R.E. Magnesium reduces free radical in an in vivo coronary occlusion-reperfusion model. J. Am. Coll. Cardiol. 32 (1998) 536-539
31. Wolff S.P., Jian Z.Y., and Hunt J.V. Protein glycation and oxidative stress in diabetes mellitus and aging. Free Radical Biol. Med. 10 (1990) 339-352
32. Kenney M.A., and McCoy J.H. Magnesium deficiency n the rat: effects of fructose, boron and copper. Magnesium Res. 13 (2000) 19-27